Questions a plan sponsor actually asks.
What is Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide used for?
Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide reduces fluid retention and lowers blood pressure by increasing urine output.
Is there a generic for Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide?
No. Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide is brand-only with no generic equivalents currently in market.
How much does my plan pay for Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide?
Across 329 Part D plans, Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide averages $1.13/unit (NADAC). Lowest available: $0.863/unit. Highest in distribution: $1.26/unit.
Is Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide on the FDA shortage list?
No. Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide is not currently on the FDA Drug Shortage Database.
3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (10 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.